
Falcon Edge Capital LP is a Multi-Strategy Hedge Fund based in New York, NY led by Richard Matthew Gerson, reporting $21.1B in AUM as of Q3 2025 with 48% Technology concentration, 93% concentrated in top 10 holdings, 47% allocation to QXO, and 48% technology allocation.
Largest long holdings in Falcon Edge Capital LP's portfolio (92.8% of total portfolio)
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
Software - Application Technology | $464.9M | 47.08% | — | 3.62% 24.4M shares | |
Biotechnology Healthcare | $168.3M | 17.04% | — | 12.66% 3.6M shares | |
Unknown Unknown | $124.8M | 12.64% | — | 2.26% 2.4M shares | |
Medical - Diagnostics & Research Healthcare | $40.6M | 4.12% | +$11.1M Bought | 0.69% 533.3K shares | |
Aerospace & Defense Industrials | $32.0M | 3.25% | +$5.1M Bought | 0.02% 148.5K shares | |
Aerospace & Defense Industrials | $29.8M | 3.02% | +$2.3M Bought | 0.20% 117.9K shares | |
Biotechnology Healthcare | $14.9M | 1.51% | — | 13.69% 3.7M shares | |
Medical - Instruments & Supplies Healthcare | $14.3M | 1.45% | -$732.7K Sold | 0.18% 97.1K shares | |
Unknown Unknown | $13.8M | 1.40% | +$13.8M New | 0.10% 376.2K shares | |
Packaging & Containers Consumer Cyclical | $13.2M | 1.34% | +$10.4M Bought | 0.84% 342.3K shares |
Portfolio activity, position movements, and quarter-over-quarter changes in Falcon Edge Capital LP's latest filing
| Position | Shares Δ |
|---|---|
New | |
New | |
New | |
+363.68% | |
+37.63% |
| Position | Shares Δ |
|---|---|
Sold | |
Sold | |
Sold | |
Sold | |
Sold |
Portfolio insights and performance metrics for Falcon Edge Capital LP
We use cookies for analytics. See our Privacy and Cookie Policy.